NCT00447525View on ClinicalTrials.gov

REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children

PHASE3CompletedINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
DiphtheriaTetanusPoliomyelitis
Interventions
BIOLOGICAL

REVAXIS®

BIOLOGICAL

DT-Polio®

Trial Locations (64)

13004

Marseille

14000

Caen

25000

Besançon

27270

Broglie

29000

Quimper

29200

Brest

29280

Plouzané

30129

Manduel

31000

Toulouse

33270

Floirac

33530

Bassens

34080

Montpellier

35540

Miniac-Morvan

35680

Louvigné-de-Bais

38640

Claix

41000

Blois

44230

Saint Sebastien Sur Loir

44300

Nantes

49100

Angers

49300

Cholet

50340

Les Pieux

51000

Chalon-en-champagne

51500

Chigny-les-Roses

53950

Louverné

54000

Nancy

54170

Collombey Les Belles

54390

Frouard

54700

Pont-à-Mousson

59235

Bersée

59410

Anzin

59700

Marcq-en-barouel

60190

La Neuville-Roy

62000

Arras

62210

Avion

67000

Strasbourg

67400

Illkirch-Graffenstaden

67500

Haguenau

67540

Ostwald

74000

Annecy

75013

Paris

75019

Paris

76000

Rouen

76100

Rouen

76150

Maromme

76600

Le Havre

79220

Champdeniers

81000

Albi

83110

Sanary Mer

83300

Draguignan

83700

Saint-Raphaël

86000

Poitiers

91390

Montsang/orge

91420

Morangis

92100

Boulogne

92130

Issy-les-Moulineaux

92141

Clamart

92310

Sèvres

92600

Asnières

93250

Villemomble

93400

Saint-Ouen

94130

Nogent-sur-Marne

95880

Albertville

Enghien-les-Bains

02000

Laon

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00447525 - REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children | Biotech Hunter | Biotech Hunter